Latest Pharma News

The latest pharmaceutical manufacturing news, updated daily.

Barrier to research may be removed as the public become more accepting of gene editing in animals

According to poll results from Pew Research Center, the American public is accepting of gene editing in animals that could benefit human health, potentially removing a barrier to research, as noted by a pharma analyst at GlobalData.

By PharmaManufacturingIQ Staff

/ 22 Aug 2018

Barrier to research may be removed as the public become more accepting of gene editing in animals

The countdown is on: Important considerations around the nearing EU FMD enforcement date

Earlier this month (9 August) we passed the six-month time point before all companies in Europe will be expected to comply with the falsified medicines directive (FMD).

By PharmaManufacturingIQ Staff

/ 21 Aug 2018

The countdown is on: Important considerations around the nearing EU FMD enforcement date

FDA approves first generic version of epinephrine auto-injector

The US Food and Drug Administration (FDA) has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions.

By PharmaManufacturingIQ Staff

/ 20 Aug 2018

FDA approves first generic version of epinephrine auto-injector

From molecule to medicine, the importance of persistence

Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence.

By Dr Sheuli Porkess

/ 20 Aug 2018

From molecule to medicine, the importance of persistence

Manufacturing sector contributes more than the sum of its part, note EEF/Santander

In the latest annual snapshot of the manufacturing industry — published by the manufacturers’ organisation, EEF, and Santander — it has been shown that the sector contributes more than just the sum of its part.

By PharmaManufacturingIQ Staff

/ 20 Aug 2018

Manufacturing sector contributes more than the sum of its part, note EEF/Santander

The AI will see you now — how big data and advanced analytics are changing the game in epilepsy

In this online exclusive, Erik Janssen, vice president of Global New Patient Solutions Neurology at UCB, talks about why advancements in big data and analytics might be the key to helping patients with epilepsy.

By Erik Janssen

/ 17 Aug 2018

The AI will see you now — how big data and advanced analytics are changing the game in epilepsy

Merck & InnoCore collaboration could be a step forward in biologics delivery, says GlobalData

The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData

By PharmaManufacturingIQ Staff

/ 15 Aug 2018

Merck & InnoCore collaboration could be a step forward in biologics delivery, says GlobalData

Transitioning to the cloud — drivers and challenges

Dr Stuart Ward, head of business analysis at IDBS, discusses why organisations should be considering transitioning to cloud-based software and technologies and some of the important things they should keep in mind.

By Stuart Ward

/ 15 Aug 2018

Transitioning to the cloud — drivers and challenges

Accelerating R&D innovation through an analytics centre of excellence

Bryan Plaster, VP Customer Services at Trifacta, tells us more about how establishing a centre of excellence (CoE) for data analytics can help organisations accelerate research & development (R&D).

By Bryan Plaster

/ 14 Aug 2018

Accelerating R&D innovation through an analytics centre of excellence

Falsified Medicines Directive: Six months, six thoughts

We have now passed the six month point before the Falsified Medicines Directive (FMD) comes into force. In this online exclusive, Mark Davison, senior operations director, rfxcel insists you ACT NOW! Here are six short reflections.

By Mark Davison

/ 13 Aug 2018

Falsified Medicines Directive: Six months, six thoughts

Keeping up with biologics: The challenges for primary packaging and delivery systems

Here, Rich Quelch, global head of marketing, Origin, looks at the challenges involved in primary packaging and delivery systems for biologics.

By Richard Quelch

/ 13 Aug 2018

Keeping up with biologics: The challenges for primary packaging and delivery systems

A decent proposal? What the manufacturing exemption for SPCs means

Earlier this year, the European Commission proposed the introduction of a manufacturing exemption for SPCs. Here, Alexander Kritharidis, Taylor Wessing, London, who is specialising in patents law, goes into more detail…

By Alexander Kritharidis

/ 10 Aug 2018